Literature DB >> 7541476

Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration.

D L Yao1, N R West, C A Bondy, M Brenner, L D Hudson, J Zhou, G H Collins, H D Webster.   

Abstract

To study injury-induced astrocytic responses associated with regrowth of axons and regeneration of myelin, the method of Collins and colleagues was used to make focal cryogenic lesions in spinal cords of adult rats (Collins et al.: J Neuropathol Exp Neurol 45: 742-757, 1986). The duration of cryogenic injury (CI), the size of the cryode, and its temperature were chosen to destroy all myelin sheaths and axons without producing cavities or hemorrhages. Messenger RNA and peptide distributions of insulin-like growth factor I (IGF-I), IGF-I receptor (IGFR-I), IGF binding protein 2 (IGFBP-2), glial fibrillary acidic protein (GFAP), and myelin basic protein (MBP) were studied 3-56 days after CI by in situ hybridization and immunocytochemistry. At 3 days, vimentin-positive, GFAP-negative astrocyte-like cells in the lesion expressed IGF-I mRNA and peptide and 7 days after CI, both were expressed by typical GFAP-positive, hypertrophic astrocytes, many of which also were vimentin-positive. Levels of IGF-I, IGFBP-2, and GFAP mRNA and peptide were higher in lesion astrocytes after 14 days. They attained maximum levels at 21-28 days before declining to near control levels at 56 days. Decreasing relative levels of oligodendroglial MBP mRNA were found in and around lesions 7-14 days after CI; subsequently, rising levels accompanied remyelination. At 28 and 56 days after CI, some transferrin-positive, oligodendroglia-like cells also were immunostained by anti-IGFR-I. Our findings suggest that early astrocytic production of IGF-I and IGFBP-2 may be involved in the myelin regeneration which occurs in this model of spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541476     DOI: 10.1002/jnr.490400510

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

1.  ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury.

Authors:  Michael S Beattie; Anthony W Harrington; Ramee Lee; Ju Young Kim; Sheri L Boyce; Frank M Longo; Jacqueline C Bresnahan; Barbara L Hempstead; Sung Ok Yoon
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

2.  Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging.

Authors:  Gustavo R Morel; Micaela López León; Maia Uriarte; Paula C Reggiani; Rodolfo G Goya
Journal:  Neurogenesis (Austin)       Date:  2016-12-20

Review 3.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 4.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

Review 5.  Macrophages in CNS remyelination: friend or foe?

Authors:  L T Diemel; C A Copelman; M L Cuzner
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

Authors:  J L Mason; P Ye; K Suzuki; A J D'Ercole; G K Matsushima
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 7.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

8.  Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

Authors:  A E Lovett-Racke; P Bittner; A H Cross; J A Carlino; M K Racke
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

9.  Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.

Authors:  D L Yao; X Liu; L D Hudson; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat.

Authors:  Panagiota Miltiadous; Antonios Stamatakis; Fotini Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.